These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 8376846

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
    Charan Raja MR, Velappan AB, Chellappan D, Debnath J, Kar Mahapatra S.
    Eur J Med Chem; 2017 Oct 20; 139():503-518. PubMed ID: 28826085
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Synthesis and biological evaluation of chalcones as potential antileishmanial agents.
    Gupta S, Shivahare R, Korthikunta V, Singh R, Gupta S, Tadigoppula N.
    Eur J Med Chem; 2014 Jun 23; 81():359-66. PubMed ID: 24858541
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.
    Vishwakarma P, Parmar N, Yadav PK, Chandrakar P, Kar S.
    J Mol Med (Berl); 2016 Jun 23; 94(6):695-710. PubMed ID: 26830627
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Evidence that Leishmania donovani utilizes a mannose receptor on human mononuclear phagocytes to establish intracellular parasitism.
    Wilson ME, Pearson RD.
    J Immunol; 1986 Jun 15; 136(12):4681-8. PubMed ID: 3711662
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Development and evaluation of a cedrol-loaded nanostructured lipid carrier system for in vitro and in vivo susceptibilities of wild and drug resistant Leishmania donovani amastigotes.
    Kar N, Chakraborty S, De AK, Ghosh S, Bera T.
    Eur J Pharm Sci; 2017 Jun 15; 104():196-211. PubMed ID: 28400285
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Asiaticoside induces tumour-necrosis-factor-α-mediated nitric oxide production to cure experimental visceral leishmaniasis caused by antimony-susceptible and -resistant Leishmania donovani strains.
    Bhaumik SK, Paul J, Naskar K, Karmakar S, De T.
    J Antimicrob Chemother; 2012 Apr 15; 67(4):910-20. PubMed ID: 22258930
    [Abstract] [Full Text] [Related]

  • 34. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
    Bhattacharya S, Ghosh P, De T, Gomes A, Gomes A, Dungdung SR.
    Exp Parasitol; 2013 Sep 15; 135(1):126-33. PubMed ID: 23830987
    [Abstract] [Full Text] [Related]

  • 35. Selective delivery of drugs to macrophages through a highly specific receptor. An efficient chemotherapeutic approach against leishmaniasis.
    Chaudhuri G, Mukhopadhyay A, Basu SK.
    Biochem Pharmacol; 1989 Sep 15; 38(18):2995-3002. PubMed ID: 2783154
    [Abstract] [Full Text] [Related]

  • 36. Oleanolic acid loaded poly lactic co- glycolic acid- vitamin E TPGS nanoparticles for the treatment of Leishmania donovani infected visceral leishmaniasis.
    Ghosh S, Kar N, Bera T.
    Int J Biol Macromol; 2016 Dec 15; 93(Pt A):961-970. PubMed ID: 27645930
    [Abstract] [Full Text] [Related]

  • 37. Synthesis and pharmacological evaluation of mono-arylimidamides as antileishmanial agents.
    Zhu X, Farahat AA, Mattamana M, Joice A, Pandharkar T, Holt E, Banerjee M, Gragg JL, Hu L, Kumar A, Yang S, Wang MZ, Boykin DW, Werbovetz KA.
    Bioorg Med Chem Lett; 2016 May 15; 26(10):2551-2556. PubMed ID: 27048943
    [Abstract] [Full Text] [Related]

  • 38. Mannosylated thiolated paromomycin-loaded PLGA nanoparticles for the oral therapy of visceral leishmaniasis.
    Afzal I, Sarwar HS, Sohail MF, Varikuti S, Jahan S, Akhtar S, Yasinzai M, Satoskar AR, Shahnaz G.
    Nanomedicine (Lond); 2019 Feb 15; 14(4):387-406. PubMed ID: 30688557
    [Abstract] [Full Text] [Related]

  • 39. Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis.
    Chaubey P, Mishra B.
    Carbohydr Polym; 2014 Jan 30; 101():1101-8. PubMed ID: 24299880
    [Abstract] [Full Text] [Related]

  • 40. A Replicative In Vitro Assay for Drug Discovery against Leishmania donovani.
    Tegazzini D, Díaz R, Aguilar F, Peña I, Presa JL, Yardley V, Martin JJ, Coteron JM, Croft SL, Cantizani J.
    Antimicrob Agents Chemother; 2016 Jun 30; 60(6):3524-32. PubMed ID: 27021313
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.